格隆汇公告精选(Hong Kong stocks) | hkbn (01310.HK) received a tender offer from china mobile at a offer price of approximately 40.97% premium to the closing price on November 12th.

【Today's Focus】hkbn (01310.HK) received an acquisition offer from china mobile. The offer price is approximately 40.97% higher than the closing price on November 12. hkbn (01310.HK) announced that, pending the fulfillment of conditions or exemptions, CICC will represent the offeror, china mobile hong kong limited, to submit a voluntary conditional full cash offer to acquire all issued shares (excluding those already owned by the offeror and its concert parties), and will make appropriate arrangements for all sellers' loan notes and unvested restricted share units in accordance with rule 13 of the takeover code. The offer price is 5 cash per share.

Gelonghui FinanceDec 2 10:01 ET

Affluent Partners' Fiscal H1 Loss Widens

MT NewswiresDec 2 06:06 ET

affluentpartner (01466.HK) plans to invest in Taihehuamei, aiming to achieve strategic cooperation in developing a new drug named "KMHH-03" in mainland china.

Affluentpartner (01466.HK) announced on December 2 that its indirectly wholly-owned subsidiary, Beijing Baijin Biotechnology Co., Ltd. ("Beijing Baijin"), signed a strategic cooperation framework agreement with Taihe Huamei (Zhejiang) Pharmaceutical Technology Co., Ltd. ("Taihe Huamei"). Pursuant to this, Beijing Baijin will invest in Taihe Huamei through the subscription of Taihe Huamei's equity, aiming to achieve a strategic cooperation to develop a new drug named "KMHH-03" in Mainland China. The parties to the agreement have not yet determined the actual timing and amount of the related investment. The cooperation framework agreement will expire on December 31, 2027, agreement term.

Gelonghui FinanceDec 2 05:23 ET

Express News | Affluent Partners - Agreement for Developing New Medicine Named ``Kmhh-03'' in Mainland China

ReutersDec 2 05:21 ET

Express News | Affluent Partners - Unit Entered Into a Strategic Cooperation Framework Agreement With Taihe Huamei (Zhejiang) Medical Technology Company

ReutersDec 2 05:21 ET

Affluentpartner (01466) released its interim results, with shareholders' attributable loss of 6.227 million Hong Kong dollars, a year-on-year increase of 168.64%.

Affluentpartner (01466) announced its interim results for the six months ending September 30, 2024, with revenue of 7,090...

Zhitong FinanceNov 29 06:53 ET